PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.
Wang J, Wang C, Xu P, Li X, Lu Y, Jin D, Yin X, Jiang H, Huang J, Xiong H, Ye F, Jin J, Chen Y, Xie Y, Chen Z, Ding H, Zhang H, Liu R, Jiang H, Chen K, Yao Z, Luo C, Huang Y, Zhang Y, Zhang J.
Wang J, et al. Among authors: li x.
Theranostics. 2021 Mar 12;11(11):5387-5403. doi: 10.7150/thno.42345. eCollection 2021.
Theranostics. 2021.
PMID: 33859753
Free PMC article.